Holen Sie sich die Stockscreener-App
3.57
4.08%
0.14
Handel nachbörslich:
3.52
-0.05
-1.40%
Finanzdaten der Lenz Therapeutics Inc-Aktie (LENZ)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
188.58%
5.486
|
1.901 | - | 12.50 | 5.00 |
| Cost Of Revenue |
73.98%
0.28
|
1.076 | - | - | - |
Selling, General, and Administrative
|
12.42%
39.38
|
44.96 | 39.63 | - | - |
| Costs And Expenses |
13.85%
39.66
|
46.04 | - | 29.20 | 19.41 |
| Operating Income/Loss |
22.57%
-34.17
|
-44.13 | -38.46 | -18.89 | -16.86 |
| Nonoperating Income/Loss |
14.73%
2.257
|
2.647 | 2.569 | 2.187 | 2.445 |
| Income/Loss From Continuing Operations Before Tax |
-31.91
|
- | -35.89 | -16.70 | -14.41 |
| Income Tax Expense/Benefit |
0.003
|
- | 0.002 | - | 0.50 |
| Net Income/Loss |
23.07%
-31.92
|
-41.49 | -35.90 | -16.70 | -14.91 |
| Basic Average Shares |
0.07%
31.37
|
31.35 | - | 28.54 | 28.08 |
| Diluted Average Shares |
0.07%
31.37
|
31.35 | - | 28.54 | 28.08 |
| Basic Earnings Per Share |
22.73%
-1.02
|
-1.32 | - | -0.59 | -0.53 |
| Diluted Earnings Per Share |
22.73%
-1.02
|
-1.32 | - | -0.59 | -0.53 |
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):